Moclobemide-induced hypersexuality in patients with stroke and Parkinson's disease

Clinical Neuropharmacology

Volumn 21, Issue 4, 1998, Pages 251-254

  Korpelainen, Juha T ^a,b   Hiltunen, Pirkko ^b   Myllylä, Vilho V ^b  

^a OULU DEACONESS INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Cerebrovascular disorders; Depression; Moclobemide; Parkinson's disease; Sex behavior

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BROMOCRIPTINE; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CEREBROVASCULAR DISEASE; DEPRESSION; DRUG INDUCED DISEASE; HUMAN; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; SEIZURE; SEXUAL DYSFUNCTION; STROKE; TEMPORAL LOBE EPILEPSY; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS; BENZAMIDES; CEREBROVASCULAR DISORDERS; HUMANS; MALE; MIDDLE AGED; MOCLOBEMIDE; PARKINSON DISEASE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 0031820229     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Klüver H, Bucy PC. Preliminary analysis of functions of temporal lobes in monkeys. Arch Neurol Psychiatry 1939;42:979-1000.
2. Terzian H, Ore GD. Syndrome of Klüver and Bucy reproduced in man by bilateral removal of temporal lobes. Neurology (Minneapolis) 1955;5:373-380.
3. Blumer D, Walker AE. Sexual behavior in temporal lobe epilepsy. Arch Neurol 1967;16:37-43.
4. Balon R, Yeragani VK, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993;54:209-212.
5. Zajecka J, Fawcett J, Schaff M, Feffriess H, Guy C. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 1991;52:66-67.
6. Philipp M, Kohnen R, Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol 1993;7: 149-153.
7. Lauerma H. A case of moclobemide-induced hyperorgasmia. Int Clin Psychopharmacol 1995;10:123-124.
8. Elmore JL, Quattlebaum JT. Female sexual stimulation during antidepressant treatment. Pharmacother 1997;17:612-616.
9. Monga TN, Monga M, Raina MS, Hardjasudarma M. Hypersexuality in stroke. Arch Phys Med Rehabil 1986;67:415-417.
10. Falconer MA, Hill D, Meyer A, Mitchell W, Pond DA. Treatment of temporal-lobe epilepsy by temporal lobectomy: survey of findings and results. Lancet 1955;1:827-835.
11. Savard R, Walker E. Changes in social functioning after surgical treatment for temporal lobe epilepsy. Soc Work 1965;10:87-95.
12. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375-383.
13. Vogel HP, Schiffer R. Hypersexuality - a complication of dopaminergic therapy in Parkinson's disease. Pharmacopsychiatria 1983; 16:107-110.
14. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states. Adv Neurol 1995;65:115-138.